Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Ehlers

Showing results (21-30 of 25) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 25 results.
Frontiers in Immunology|July 11, 2018
NKG2A Expression Is Not <i>per se</i> Detrimental for the Anti-Multiple Myeloma Activity of Activated Natural Killer Cells in an <i>In Vitro</i> System Mimicking the Tumor MicroenvironmentNiken M Mahaweni, Femke A I Ehlers, Subhashis Sarkar, et al.
HLA|June 1, 2022
Polymorphic differences within HLA-C alleles contribute to alternatively spliced transcripts lacking exon 5Femke A I Ehlers, Timo I Olieslagers, Mathijs Groeneweg, et al.
Cancers|July 2, 2021
ADCC-Inducing Antibody Trastuzumab and Selection of KIR-HLA Ligand Mismatched Donors Enhance the NK Cell Anti-Breast Cancer ResponseFemke A I Ehlers, Nicky A Beelen, Michel van Gelder, et al.
Cancers|June 2, 2021
Defucosylation of Tumor-Specific Humanized Anti-MUC1 Monoclonal Antibody Enhances NK Cell-Mediated Anti-Tumor Cell CytotoxicityYing Gong, Roel G J Klein Wolterink, Valeriia Gulaia, et al.
Breast Cancer Research : BCR|January 25, 2025
Natural killer cells occupy unique spatial neighborhoods in HER2<sup>-</sup> and HER2<sup>+</sup> human breast cancersFemke A I Ehlers, Katie E Blise, Courtney B Betts, et al.
Pageof 3

Showing results (21-30 of 25) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
Frontiers in Immunology|July 11, 2018
NKG2A Expression Is Not <i>per se</i> Detrimental for the Anti-Multiple Myeloma Activity of Activated Natural Killer Cells in an <i>In Vitro</i> System Mimicking the Tumor MicroenvironmentNiken M Mahaweni, Femke A I Ehlers, Subhashis Sarkar, et al.
HLA|June 1, 2022
Polymorphic differences within HLA-C alleles contribute to alternatively spliced transcripts lacking exon 5Femke A I Ehlers, Timo I Olieslagers, Mathijs Groeneweg, et al.
Cancers|July 2, 2021
ADCC-Inducing Antibody Trastuzumab and Selection of KIR-HLA Ligand Mismatched Donors Enhance the NK Cell Anti-Breast Cancer ResponseFemke A I Ehlers, Nicky A Beelen, Michel van Gelder, et al.
Cancers|June 2, 2021
Defucosylation of Tumor-Specific Humanized Anti-MUC1 Monoclonal Antibody Enhances NK Cell-Mediated Anti-Tumor Cell CytotoxicityYing Gong, Roel G J Klein Wolterink, Valeriia Gulaia, et al.
Breast Cancer Research : BCR|January 25, 2025
Natural killer cells occupy unique spatial neighborhoods in HER2<sup>-</sup> and HER2<sup>+</sup> human breast cancersFemke A I Ehlers, Katie E Blise, Courtney B Betts, et al.
Pageof 3